Policy & Regulation
Charles River Forges Strategic Partnership with Bit Bio, Increasing Portfolio of Translational Drug Discovery Technologies
12 December 2019 - - US-based Charles River Laboratories International, Inc. (NYSE: CRL) has entered into an exclusive Discovery and Safety Services partnership with Bit Bio, a company that offer...
US Patent Issued for Method of Generating Induced Pluripotent Stem Cells
12 December 2019 - - The United States Patent and Trademark Office (USPTO) has issued US Patent No. 10,501,723, entitled "Methods of Reprogramming Animal Somatic Cells" covering what is comm...
Moderna Names Nader to Board of Directors
12 December 2019 - - Former CEO of NPS Pharmaceuticals brings broad expertise to support Moderna's progress towards late-stage development and commercialization

US-based clinical sta...
Leo Pharma Joins Certara's PBPK Simcyp Simulator Consortium
12 December 2019 - - Danish pharmaceutical company Leo Pharma has licensed US-based model-informed drug development and decision support Certara's proprietary Simcyp Population-based Simulator an...
DarzalexRegimen Shows Significant Increase in Progression-Free Survival in Treatment of Patients with Relapsed/Refractory Multiple Myeloma
12 December 2019 - - US-based healthcare company Johnson and Johnson's (NYSE: JNJ) The Janssen Pharmaceutical Companies business has received results from the Phase 3 CANDOR study showing that th...
Phoenix Biotechnology concludes USD4.12m private placement
12 December 2019 - Phoenix Biotechnology Inc stated on Wednesday that it has raised gross proceeds of USD4.12m from a private placement of common stock.Under the private placement, the company sold 1,...
Related Headlines

US FDA grants Dermira's lebrikizumab fast track designation

Engitix and Morphic Enter Research Collaboration to Identify ECM-Related Targets in Fibrostenotic Inflammatory Bowel Disease

Dyve Biosciences Receives FDA Clearance to Begin Phase 2 Study of DYV-700 for Treatment of Acute Gout Pain

Bristol-Myers Squibb Presents Overall Survival and Safety Data from Pivotal CC-486 Study QUAZAR AML-001

Vertex Wins European Commission Nod for Kalydeco in Infants with Cystic Fibrosis Ages 6 Months to Less Than 12 Months with Certain Mutations in the CFTR Gene

Sage Therapeutics Plans to Advance of SAGE-718 to Phase 2 in Huntington's Disease and Presentations at the 2019 annual meeting of the American College of Neuropsychopharmacology

Inscripta Raises USD 125m in Series D Financing

Genentech submits Xolair sBLA with FDA for the treatment of nasal polyps in adult patients

Prometheus Biosciences names new chief development officer, diagnostics, and medical laboratory director

Incheon Metropolitan City government to develop Songdo Global Biotech Cluster in Incheon Free Economic Zone

Novartis reveals results from two analyses of real-world experience with Kymriah

Shattuck Labs welcomes Casi DeYoung as CBO

Samyang Biopharm USA partners with Talix Therapeutics NV to advance novel immuno-oncology therapy

Engitix partners with Morphic to identify ECM related targets in fibrostenotic inflammatory bowel disease

InMed Pharmaceuticals granted Clinical Trial Application approval for INM-755 phase one trial